Form 4 Filing: Dambkowski Carl Sells 8000 Shares of Common Stock in Apogee Therapeutics, Inc.

Carl Dambkowski, Chief Medical Officer of Apogee Therapeutics, Inc., reported the disposition of 8000 shares of Common Stock on July 14, 2026. The transaction, coded as a gift (G), resulted in zero proceeds per share. This disposition is noted as a bona fide gift to a donor-advised fund. Following this transaction, Mr. Dambkowski directly owns 169,873 shares of Apogee Therapeutics, Inc. common stock. The filing was signed by Matthew Batters as attorney-in-fact for Carl Dambkowski.